Cocrystallization of lenvatinib and temozolomide to improve the performance in terms of stability, dissolution, and tabletability

Zhi-Qing Wang,Xia-Lin Dai,Dai-Lin Gu,Chao Wu,Tong-Bu Lu,Xiang-Tian Long,Jia-Mei Chen
DOI: https://doi.org/10.1039/d3ce00473b
IF: 3.756
2023-01-01
CrystEngComm
Abstract:Two anti-melanoma drugs, lenvatinib and temozolomide, were cocrystallized to obtain two drug-drug cocrystal solvates, TMZ-LEN & BULL;MeOH (1 : 1 : 1) and TMZ-LEN & BULL;EtOH (1 : 1 : 1). They were fully characterized by XRD and thermal analyses, NMR and FTIR spectroscopy. The crystal structure of TMZ-LEN & BULL;MeOH shows that LEN is simultaneously linked to TMZ and methanol via hydrogen bonding interactions. Stability, dissolution and compaction evaluations highlight that the formation of the drug-drug cocrystal not only improves the physicochemical stability and tabletability of TMZ, but also optimizes the dissolution behavior of LEN and TMZ, respectively. Therefore, TMZ-LEN & BULL;MeOH and TMZ-LEN & BULL;EtOH have great potential to be developed as a drug combination, which will address the problematic properties of LEN and TMZ, for the treatment of melanoma patients with brain metastases.
What problem does this paper attempt to address?